• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心脏内皮细胞表达功能活性人CD59的转基因猪的特性分析。

Characterization of transgenic pigs expressing functionally active human CD59 on cardiac endothelium.

作者信息

Diamond L E, McCurry K R, Martin M J, McClellan S B, Oldham E R, Platt J L, Logan J S

机构信息

Nextran, Princeton, NJ 08540, USA.

出版信息

Transplantation. 1996 Apr 27;61(8):1241-9. doi: 10.1097/00007890-199604270-00021.

DOI:10.1097/00007890-199604270-00021
PMID:8610425
Abstract

The critical shortage of human donor organs has generated interest in the potential for porcine to human xenotransplantation. The initial immunological barrier to xenotransplantation is hyperacute rejection, which is mediated by xenoreactive antibodies and complement, and results in rapid and irreversible tissue destruction. While endogenous complement regulatory proteins (CRPs) protect cells from injury caused by autologous complement, they are relatively species specific and most likely ineffectual in this setting. This has led to the hypothesis that expression of human CRPs in transgenic pigs may affect susceptibility to complement-mediated tissue injury in a porcine-to-human xenograft. Using specific lines of transgenic pigs that express low levels of human CD59, a CRP that acts at the terminal stage of the complement cascade, we present evidence that shows that the human CD59 protein inhibits membrane attack complex assembly and reduces tissue damage when the heart is transplanted to a baboon. Examination by immunohistochemistry of transgenic porcine hearts after transplantation revealed markedly reduced deposition of C5b and MAC, but a similar level of C3 deposition as compared with transplanted control hearts. This finding supports the concept that the species specific function of CRPs contributes to the humoral barrier to xenotransplantation and, given the low level of human CD59 protein expression in the porcine heart, argues that the human protein contributes a unique rather than an additive function in regulation of complement in a xenogeneic setting.

摘要

人类供体器官的严重短缺引发了人们对猪到人的异种移植潜力的兴趣。异种移植最初的免疫屏障是超急性排斥反应,它由异种反应性抗体和补体介导,会导致迅速且不可逆的组织破坏。虽然内源性补体调节蛋白(CRP)可保护细胞免受自身补体造成的损伤,但它们具有相对的物种特异性,在这种情况下很可能无效。这就引出了一个假说,即在转基因猪中表达人类CRP可能会影响猪到人的异种移植中补体介导的组织损伤易感性。我们使用表达低水平人类CD59(一种在补体级联反应末期起作用的CRP)的特定转基因猪品系,提供了证据表明,当心脏移植到狒狒体内时,人类CD59蛋白可抑制膜攻击复合物的组装并减少组织损伤。移植后对转基因猪心脏进行免疫组织化学检查发现,C5b和MAC的沉积明显减少,但与移植的对照心脏相比,C3沉积水平相似。这一发现支持了CRP的物种特异性功能促成异种移植体液屏障的概念,并且鉴于猪心脏中人类CD59蛋白的低表达水平,表明人类蛋白在异种环境中对补体的调节发挥的是独特而非附加的功能。

相似文献

1
Characterization of transgenic pigs expressing functionally active human CD59 on cardiac endothelium.心脏内皮细胞表达功能活性人CD59的转基因猪的特性分析。
Transplantation. 1996 Apr 27;61(8):1241-9. doi: 10.1097/00007890-199604270-00021.
2
The pig analogue of CD59 protects transgenic mouse hearts from injury by human complement.CD59的猪类似物可保护转基因小鼠心脏免受人类补体的损伤。
Transplantation. 2000 Sep 27;70(6):963-8. doi: 10.1097/00007890-200009270-00014.
3
Expression of human CD59 in transgenic pig organs enhances organ survival in an ex vivo xenogeneic perfusion model.人CD59在转基因猪器官中的表达可提高离体异种灌注模型中器官的存活率。
Transplantation. 1996 May 27;61(10):1513-21. doi: 10.1097/00007890-199605270-00018.
4
Human CD59 expressed in transgenic mouse hearts inhibits the activation of complement.在转基因小鼠心脏中表达的人CD59可抑制补体的激活。
Transpl Immunol. 1995 Dec;3(4):305-12. doi: 10.1016/0966-3274(95)80016-6.
5
Cytomegalovirus early promoter induced expression of hCD59 in porcine organs provides protection against hyperacute rejection.巨细胞病毒早期启动子诱导猪器官中hCD59的表达可防止超急性排斥反应。
Transplantation. 2001 Dec 27;72(12):1898-906. doi: 10.1097/00007890-200112270-00006.
6
Transgenic porcine valves show no signs of delayed cardiac xenograft rejection.转基因猪瓣膜未显示出心脏异种移植延迟排斥的迹象。
Ann Thorac Surg. 2001 May;71(5 Suppl):S389-92. doi: 10.1016/s0003-4975(01)02505-x.
7
Transgenic pigs expressing human CD59 and decay-accelerating factor produce an intrinsic barrier to complement-mediated damage.表达人CD59和衰变加速因子的转基因猪对补体介导的损伤产生内在屏障。
Transplantation. 1997 Jan 15;63(1):149-55. doi: 10.1097/00007890-199701150-00027.
8
Transgenic expression of human complement regulatory proteins in mice results in diminished complement deposition during organ xenoperfusion.人类补体调节蛋白在小鼠中的转基因表达导致器官异种灌注期间补体沉积减少。
Transplantation. 1995 Apr 27;59(8):1177-82.
9
Hearts from transgenic pigs constructed with CD59/DAF genomic clones demonstrate improved survival in primates.用CD59/DAF基因组克隆构建的转基因猪的心脏在灵长类动物中显示出存活率提高。
Xenotransplantation. 1999 Aug;6(3):194-200. doi: 10.1034/j.1399-3089.1999.00017.x.
10
Human complement regulatory proteins protect swine-to-primate cardiac xenografts from humoral injury.人类补体调节蛋白可保护猪到灵长类动物的心脏异种移植免受体液损伤。
Nat Med. 1995 May;1(5):423-7. doi: 10.1038/nm0595-423.

引用本文的文献

1
Current status and prospects of genetically modified porcine-to-human cardiac xenotransplantation.基因编辑猪到人的心脏异种移植的现状与展望
J Artif Organs. 2025 May 4. doi: 10.1007/s10047-025-01504-z.
2
Genetic engineering of pigs for xenotransplantation to overcome immune rejection and physiological incompatibilities: The first clinical steps.猪的异种移植遗传工程以克服免疫排斥和生理不相容性:临床的第一步。
Front Immunol. 2022 Dec 6;13:1031185. doi: 10.3389/fimmu.2022.1031185. eCollection 2022.
3
Complement-targeted therapies in kidney transplantation-insights from preclinical studies.
补体靶向治疗在肾移植中的研究进展。
Front Immunol. 2022 Oct 13;13:984090. doi: 10.3389/fimmu.2022.984090. eCollection 2022.
4
Advance of genetically modified pigs in xeno-transplantation.转基因猪在异种移植中的研究进展。
Front Cell Dev Biol. 2022 Oct 10;10:1033197. doi: 10.3389/fcell.2022.1033197. eCollection 2022.
5
Aspects of the Complement System in New Era of Xenotransplantation.补体系统在新时代异种移植中的作用
Front Immunol. 2022 Apr 14;13:860165. doi: 10.3389/fimmu.2022.860165. eCollection 2022.
6
The complex functioning of the complement system in xenotransplantation.异种移植中补体系统的复杂功能。
Xenotransplantation. 2019 Jul;26(4):e12517. doi: 10.1111/xen.12517. Epub 2019 Apr 29.
7
Genetically-engineered pigs as sources for clinical red blood cell transfusion: What pathobiological barriers need to be overcome?基因工程猪作为临床红细胞输血的来源:需要克服哪些病理生物学障碍?
Blood Rev. 2019 May;35:7-17. doi: 10.1016/j.blre.2019.01.003. Epub 2019 Jan 28.
8
Immune modulation in xenotransplantation.异种移植中的免疫调节
Arch Immunol Ther Exp (Warsz). 2015 Jun;63(3):181-92. doi: 10.1007/s00005-014-0317-7. Epub 2014 Oct 30.
9
Production of multiple transgenic Yucatan miniature pigs expressing human complement regulatory factors, human CD55, CD59, and H-transferase genes.生产表达人补体调控因子、人 CD55、CD59 和 H-转移酶基因的多个转基因尤卡坦微型猪。
PLoS One. 2013 May 21;8(5):e63241. doi: 10.1371/journal.pone.0063241. Print 2013.
10
Clinical islet xenotransplantation: how close are we?临床胰岛异种移植:我们距离成功还有多远?
Diabetes. 2012 Dec;61(12):3046-55. doi: 10.2337/db12-0033.